| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3996865 | Practical Radiation Oncology | 2014 | 7 Pages |
Abstract
Mediastinal IFRT for lymphoma delivered with mDIBH can significantly reduce lung and heart dose compared with FB, although not for all patients, and may increase breast dose in females. Its implementation is achievable in both adult and pediatric populations. Further work is necessary to better predict which patients benefit from this technique.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Anne-Marie MD FRCPC, Tatiana MD, Jenna MMath, Angela MEd RTT, Rachel HBSc RTT, Amy BSc MRT(T), Catherine PhD, Richard W. MD FRCPC, Mary K. MD FRCPC, Alexander MD FRCPC, David C. MD FRCPC,